For decades, drug hunters focused on proteins, but many diseases are caused by problems at the RNA level. What if you could take a simple pill that fixes this genetic miscommunication? Enter RNA-Targeted Small Molecules—a groundbreaking new class of medicine that combines the precision of genetic therapy with the convenience of a traditional pill.